IRIS

Chlordecone (Kepone)

CASRN 143-50-0 | DTXSID1020770

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (24 pp, 231 K) Last Updated: 09/22/2009

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Urinary 3 x 10 -4 Renal lesions (glomerulosclerosis) in female Wistar rats BMDL 10 : 0.08
mg/kg-day
300 Medium

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (24 pp, 231 K) Last Updated: 09/22/2009
Information reviewed but value not estimated.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (24 pp, 231 K) Last Updated: 09/22/2009

WOE Characterization Framework for WOE Characterization
Likely to be carcinogenic to humans Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005)
Basis:
  • Under the U.S. EPA Guidelines for Carcinogen Risk Assessment (U.S. EPA, 2005a), chlordecone is "likely to be carcinogenic to humans" based on data from an oral cancer bioassay in rats and mice demonstrating an increase in the incidence of hepatocellular carcinomas in both sexes of both species (NCI, 1976a, b).
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (24 pp, 231 K)

Oral Slope Factor: 1 x 101 per mg/kg-day
Drinking Water Unit Risk: 3 x 10-4 per µg/L
Extrapolation Method: Multistage-Weibull model (implemented in TOX_RISK) with linear extrapolation from the POD (BMDL10).
Tumor site(s): Hepatic
Tumor type(s): liver hepatocellular carcinoma (NCI (1976a))


Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (24 pp, 231 K)

Information reviewed but value not estimated.

Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.